Not from Advocate Health - Midwest? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.


Works from 2022


Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients, Alvin F. Wells, Christopher J Edwards, Alan J Kivitz, et al. (Article)


A review of the abscopal effect in the era of immunotherapy, Edward Nabrinsky, Jason Macklis, and Jacob Bitran (Article)


Baseline disease activity predicts achievement of cDAPSA treatment targets with apremilast: Phase 3 results in DMARD-naive patients with psoriatic arthritis, Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, et al. (Article)


Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease, Song Lu, John V. White, Ifeyinwa Nwaneshiudu, et al. (Article)

Lymphadenopathy, Sarah Burroughs and Evan Kang (Book Chapter)


Optimizing asthma management: Role of long-acting muscarinic antagonists, Thomas B. Casale, Michael B. Foggs, and Ronald C. Balkissoon (Article)


Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: When will we achieve parity?, Jagannadha Avasarala, Phenu Zachariah, and Breck Turner (Article)


The role of physician advocacy in achieving health equity: Where is the allergist-immunologist?, Margee Louisias, Roselyn Hicks, Samantha Jacobs, et al. (Article)

Works from 2020


How does stellate ganglion block alleviate immunologically-linked disorders?, Eugene Lipov, Vicko Gluncic, Ivan K Lukić, et al. (Article)


Reasons for hospitalization and in-hospital mortality in adult systemic lupus erythematosus, Augustine M Manadan, Soumyasri Kambhatla, Estefania Gauto-Mariotti, et al. (Article)


Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY, Vibeke Strand, Namita Tundia, Alvin Wells, et al. (Article)


Work Group Report: COVID-19: Unmasking Telemedicine, Nathan Hare, Priya Bansal, Sakina S Bajowala, et al. (Article)

Works from 2006

A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4, Dhanalakshmi Chinnasamy, Matt Tector, Nachimuthu Chinnasamy, et al. (Article)

Effect of targeting BTLA-HVEM co-inhibitory pathway in partial MHC-mismatched cardiac grafts, V Vadivel, J Yang, V K. Vanguri, et al. (Abstract)

Works from 2005

Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population, Cai Lei, Zhang Dongqing, Shi Yeqing, et al. (Article)

CTLA-4 is important in maintaining long-term survival of cardiac allografts, Anil Chandraker, Volkert Huurman, Karen Hallett, et al. (Article)

Expression of FOX-P3, GATA-3, and GITR during tolerance and breaking of tolerance: Abstract #221., Willem-jan Flu, Anna-Maria Wagga, Volkert Huurman, et al. (Abstract)

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination, Nachimuthu Chinnasamy, Martin Oaks, J S. Treisman, et al. (Article)

Works from 2003

Alloimmune induction of endothelial cell-derived interferon-gamma-inducible chemokines, Raghavanpillai Raju, Angela Malloy, Tara Shah, et al. (Article)

A novel monoclonal anti-rat CTLA4 antibody abrogates longterm cardiac allograft survival induced by anti-CD28/CSA, Xueli Yuan, Volkert Huurman, Alan D. Salama, et al. (Abstract)

Works from 2000

A native soluble form of CTLA-4, Martin Oaks, Karen Hallett, R T Penwell, et al. (Article)

Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease, Martin Oaks and Karen M. Hallett (Article)

Works from 1992

The effect of cimetidine on lymphocyte subpopulations in vivo in experimental mice, A Kumar, Martin K. Oaks, and K J Kelly (Article)